Loading…
Senzime AB announced that a leading UK NHS hospital trust has ordered 70 TetraGraph systems for neuromuscular monitoring, secured through partner Healthcare 21. Annual usage is expected to exceed 15,000 TetraSens sensors at full implementation.
“This is a strategic win for us in the UK market and a clear signal that the NHS is accelerating the transition to the latest advancements in neuromuscular monitoring.”senzime.com
Summarized from public sources; check the original articles before acting on it.